Brief: Genoway FY EBITDA Down At 0.5 Million Euros

genOway SA

26/03/2020 17:00

March 26 (Reuters) - 
    * FY REVENUE EUR 9.5 MILLION VERSUS EUR 10.8 MILLION YEAR
AGO
    * FY EBITDA EUR 0.5 MILLION VERSUS EUR 1.4 MILLION YEAR AGO
    * FY NET LOSS EUR 1.0 MILLION VERSUS PROFIT EUR 0.6 MILLION
YEAR
AGO
    * CONFIRMATION OF 2024 TARGETS
    * WE FULLY CONFIRM OUR 2024 AMBITION, WHICH AIMS TO INCREASE
GENOWAY'S SALES TO EUR 30 MILLION AND EBITDA MARGIN TO 25% - CEO
    * AS OF DEC 31, 2019, GENOWAY'S SHAREHOLDERS' EQUITY STOOD
AT EUR
6.8 MILLION
    * GROSS FINANCIAL DEBT AMOUNTED TO EUR 6.0 MILLION AT END OF
2019
    * ANTICIPATES STRONG ACCELERATION OF ITS SALES GROWTH OVER
NEXT
FIVE YEARS, WITH AVERAGE ANNUAL GROWTH TARGETED BETWEEN 25% AND
35% OVER PERIOD 2020-2024
    * TO DATE, ESTIMATED IMPACT OF COVID-19 ON GENOWAY'S
BUSINESS
REMAINS LIMITED
    * SOME PROJECTS ARE LIKELY TO BE POSTPONED OVER TIME DUE TO
CORONAVIRUS
    * MAINTAINS PRODUCTION AT SLIGHTLY DEGRADED LEVEL WHILE
STRICTLY
OBSERVING SAFETY INSTRUCTIONS

Source text for Eikon:  ID:nACT62676 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))